Clinical Trials in New York

Showing 7141-7160 of 22,668 trials

CYPRESS Efficacy and Safety Study Extension

NCT04947735

This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.

Juvenile MyopiaMyopia

SightGlass Vision, Inc.200 participantsStarted Jul 2021

Whittier, California, United States • Longwood, Florida, United States • Pittsburg, Kansas, United States +9 more locations

TERMINATEDNA< 1 mile

Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD

NCT03901534

The purpose of this study is to evaluate whether biomarkers of lung epithelial and endothelial injury are associated with obstructive sleep apnea (OSA) and interstitial lung disease (ILD).

Interstitial Lung DiseaseObstructive Sleep Apnea

Columbia University2,021 participantsStarted Jan 2023

Boston, Massachusetts, United States • New York, New York, United States

CYPRESS Efficacy and Safety Study Extension

Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD

Find Trials by Condition in New York

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

The Hospice Advanced Dementia Symptom Management and Quality of Life Trial (HAS-QOL)

Cannabidiol in the Treatment of Opioid Use Disorder

Digital Mental Health Care for COVID-19 High-Risk Populations - Phase 2

MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis

Motivation Skills Training for Schizophrenia

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma

Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films

A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS

Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma